Malignant pleural mesothelioma: current concepts in treatment
Athanasios Tsiouris* and Robin K Walesby
Correspondence *Basement flat 2, 359 Camden Road, London N7 0SH, UK
Email athtsiouris@hotmail.com
Malignant pleural mesothelioma (MPM) is a common primary tumor of the pleura. Current therapeutic regimens that involve surgery, chemotherapy and radiotherapy have offered marginal clinical benefits. Histological subtype, lymph-node involvement, resection margins and invasion beyond the pleura are significant factors that dictate survival. This review discusses the multimodality approach, which is considered the cornerstone of treatment of MPM, although the authors emphasize that the exact combination of treatment options for this disease have yet to be defined.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$32 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.